Sebens Müerköster, Susanne <br/><br/>
alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.  [electronic resource] 

 -  International journal of oncology  Jan 2009 
 - 243-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1019-6439 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Caspases--metabolism<br/>Drug Resistance, Neoplasm<br/>Etoposide--therapeutic use<br/>Flow Cytometry<br/>Humans<br/>Integrin alpha5--physiology<br/>Mutagenesis, Site-Directed<br/>Neural Cell Adhesion Molecule L1--genetics<br/>Nitric Oxide Synthase Type II--metabolism<br/>Pancreatic Neoplasms--drug therapy<br/>RNA, Messenger--genetics<br/>RNA, Small Interfering--pharmacology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transfection<br/>Tumor Cells, Cultured